The market for biotech initial public offerings has been en fuego in recent months as this niche has seen more companies come public than in 2019. The IPOs have been spurred on in part by the massive sums put toward new Covid-19 tests, vaccines and treatmentsOn the other hand, merger-and-acquisition activity in this space has been tepid compared t...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.